G
Gujarat Themis Biosyn Ltd
Pharmaceuticals
SMALLCAP
Pharmaceuticals
Live Performance vs
Current value of ₹ 100 invested once
3 years
ago would beGujarat Themis Biosyn Ltd
₹ 493.77
Equity Smallcap
₹ 150.72
This is a tool to communicate factual return information and should not be seen as an advertisement or promotion
| Key Metrics | This Stock | Category (Avg) |
| PE Ratio | 45.02 | 49.03 |
| PB Ratio | 13.22 | 6.24 |
| Dividend Yield | 1.36% | 0.54% |
Understand what these metrics mean.
Peer Stocks
For peer comparison & financials,
About the company
G
Gujarat Themis Biosyn Ltd
The company makes bulk drugs. It's R&D division focuses on developing fermentation cultures. The Company's products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis...
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions
Before you move ahead
Understand Key Terms
Live Performance
It depicts the actual and verifiable returns generated by the portfolios of SEBI registered entities. Live performance does not include any backtested data or claim and does not guarantee future returns
Disclosures
By proceeding, you understand that investments are subjected to market risks and agree that returns shown on the platform were not used as an advertisement or promotion to influence your investment decisions